Literature DB >> 18697225

The role of twist during palate development.

Wenli Yu1, Harold Kamara, Kathy K H Svoboda.   

Abstract

In palatogenesis, the MEE (Medial Edge Epithelium) cells disappear when palates fuse. We hypothesize that the MEE cells undergo EMT (Epithelial-Mesenchymal Transition) to achieve mesenchyme confluence. Twist has an important role in EMT for tumor metastasis. The purpose of this study was to analyze Twist function during palatal fusion. Twist protein was expressed in palatal shelves and MEE both in vivo and in vitro just prior to fusion. Twist mRNA increased in chicken palates 3 and 6 hr after TGFbeta3 treatment. Palatal fusion was decreased when cultured palatal shelves were treated with 200 nM Twist siRNA and the subcellular localization of beta-catenin was altered. Twist mRNA decreased in palatal shelves treated with TGFbeta3 neutralizing antibody or LY294002, a specific phosphatidylinositol-3 kinase (PI-3K) inhibitor. In summary, Twist is downstream of TGFbeta3 and PI-3K pathways during palatal fusion. However, decreasing Twist with siRNA did not completely block palate fusion, indicating that the function of Twist may be duplicated by other transcription factors. Copyright (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18697225     DOI: 10.1002/dvdy.21627

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  26 in total

1.  Induction of palate epithelial mesenchymal transition by transforming growth factor β3 signaling.

Authors:  Azadeh Jalali; Xiujuan Zhu; ChangChih Liu; Ali Nawshad
Journal:  Dev Growth Differ       Date:  2012-07-08       Impact factor: 2.053

Review 2.  Biomarkers for epithelial-mesenchymal transitions.

Authors:  Michael Zeisberg; Eric G Neilson
Journal:  J Clin Invest       Date:  2009-06-01       Impact factor: 14.808

Review 3.  TGF-β Family Signaling in Epithelial Differentiation and Epithelial-Mesenchymal Transition.

Authors:  Kaoru Kahata; Mahsa Shahidi Dadras; Aristidis Moustakas
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-01-02       Impact factor: 10.005

4.  Infusion of Gabrα6 siRNA into the trigeminal ganglia increased the myogenic orofacial nociceptive response of ovariectomized rats treated with 17β-estradiol.

Authors:  P R Kramer; L L Bellinger
Journal:  Neuroscience       Date:  2014-08-12       Impact factor: 3.590

5.  Spatiotemporal localization of periostin and its potential role in epithelial-mesenchymal transition during palatal fusion.

Authors:  Yukiko Kitase; Keisuke Yamashiro; Katherine Fu; Joy M Richman; Charles F Shuler
Journal:  Cells Tissues Organs       Date:  2010-11-03       Impact factor: 2.481

Review 6.  Palate morphogenesis: current understanding and future directions.

Authors:  Robert M Greene; M Michele Pisano
Journal:  Birth Defects Res C Embryo Today       Date:  2010-06

Review 7.  Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.

Authors:  Douglas S Micalizzi; Susan M Farabaugh; Heide L Ford
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-19       Impact factor: 2.673

8.  TWIST1 promotes invasion through mesenchymal change in human glioblastoma.

Authors:  Svetlana A Mikheeva; Andrei M Mikheev; Audrey Petit; Richard Beyer; Robert G Oxford; Leila Khorasani; John-Patrick Maxwell; Carlotta A Glackin; Hiroaki Wakimoto; Inés González-Herrero; Isidro Sánchez-García; John R Silber; Philip J Horner; Robert C Rostomily
Journal:  Mol Cancer       Date:  2010-07-20       Impact factor: 27.401

9.  Matrix metalloproteinase-25 has a functional role in mouse secondary palate development and is a downstream target of TGF-β3.

Authors:  Graham D Brown; Adil J Nazarali
Journal:  BMC Dev Biol       Date:  2010-09-01       Impact factor: 1.978

10.  Cleft lip and palate genetics and application in early embryological development.

Authors:  Wenli Yu; Maria Serrano; Symone San Miguel; L Bruno Ruest; Kathy K H Svoboda
Journal:  Indian J Plast Surg       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.